MIL OSI Translation. Region: Russian Federation –
Orders dated January 25, 2022 No. 69-r, No. 70-r
Order dated January 25, 2022 No. 69-r
Order dated January 25, 2022 No. 70-r
Over 20 billion rubles have been additionally allocated from the reserve fund for medicines for patients with coronavirus infection. The order to this effect was signed by Prime Minister Mikhail Mishustin.
Most of the funds – over 15 billion rubles – will be used to purchase medicines not registered in Russia for the treatment of patients in hospitals. We are talking about the purchase of at least 200,000 packs of molnupiravir and at least 78,456 packs of thixagevimab + cilgavimab. Also on the list of purchases are at least 3.1 thousand vials of sotrovimab and at least 515 thousand packages of remdesivir.
The centralized procurement of these drugs will be carried out by the Federal Center for Planning and Organization of Drug Provision of Citizens, subordinate to the Russian Ministry of Health. Then the medicines will go to regional hospitals and polyclinics, as well as to federal medical organizations.
The rest of the funds – more than 5 billion rubles – will be directed to the regions to provide medicines to patients who receive medical care on an outpatient basis, that is, they are treated at home under the supervision of doctors. To prevent the unfavorable course of the disease and the development of complications, they are prescribed combined treatment regimens. All necessary drugs are issued free of charge by prescription of the attending physician. Additional funding will provide more than 830,000 people with drugs.
The issue of allocating funding from the reserve fund was discussed at an extended meeting of the Coordinating Council to combat the spread of coronavirus infection January 18th. Then the relevant draft orders were reviewed and approved at the meeting of the Government on January 21.
EDITOR’S NOTE: This article is a translation. Apologies should the grammar and or sentence structure not be perfect.